Literature DB >> 6822240

Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism.

M Fuss, C Gillet, J Simon, J C Vandewalle, A Schoutens, P Bergmann.   

Abstract

Bone mineral content (BMC) was measured with the Norland Cameron apparatus in 120 renal stone formers (RSF) with idiopathic stone disease and in 41 patients with primary hyperparathyroidism. RSF were classified, according to an oral calcium load test, into three groups: no hypercalciuria (HC; 41 cases); absorptive HC (53 cases), and resorptive or renal HC (25 cases). BMC values in RSF as a group were significantly lower than normal (p less than 0.001, Mann-Whitney test) though higher than in hyperparathyroid patients. There was a trend for BMC to decrease from male RSF without HC to patients with renal or resorptive HC. No statistical difference was found between the groups, however, BMC values in absorptive HC were different from normal (p less than 0.001). Why patients with HC are demineralized is unclear since no correlation was found between BMC and basal values of serum phosphate, TRP, calculated TmP/GFR, urinary calcium or hydroxyproline. Nevertheless our results indicate that urolithiasis, and possibly its treatment, is not a benign condition for the skeleton.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822240     DOI: 10.1159/000474039

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  9 in total

Review 1.  Bone disease and idiopathic hypercalciuria.

Authors:  Joseph E Zerwekh
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

2.  Involvement of low-calcium diet in the reduced bone mineral content of idiopathic renal stone formers.

Authors:  M Fuss; T Pepersack; J Van Geel; J Corvilain; J C Vandewalle; P Bergmann; J Simon
Journal:  Calcif Tissue Int       Date:  1990-01       Impact factor: 4.333

Review 3.  Nephrolithiasis-associated bone disease: pathogenesis and treatment options.

Authors:  Khashayar Sakhaee; Naim M Maalouf; Rajiv Kumar; Andreas Pasch; Orson W Moe
Journal:  Kidney Int       Date:  2010-12-01       Impact factor: 10.612

4.  Long-term potassium citrate therapy and bone mineral density in idiopathic calcium stone formers.

Authors:  F Vescini; A Buffa; G La Manna; A Ciavatti; E Rizzoli; A Bottura; S Stefoni; R Caudarella
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

5.  Prevalence and densitometric characteristics of incomplete distal renal tubular acidosis in men with recurrent calcium nephrolithiasis.

Authors:  Spyridon Arampatzis; Barbara Röpke-Rieben; Kurt Lippuner; Bernhard Hess
Journal:  Urol Res       Date:  2011-06-29

6.  Bone disease in primary hypercalciuria.

Authors:  Stefania Sella; Catia Cattelan; Giuseppe Realdi; Sandro Giannini
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

7.  Bone mineral density measurement in patients with recurrent normocalciuric calcium stone disease.

Authors:  Volkan Tugcu; Emin Ozbek; Bekir Aras; Bedi Ozbay; Filiz Islim; Ali Ihsan Tasci
Journal:  Urol Res       Date:  2006-12-12

Review 8.  Bone mineral content in calcium renal stone formers.

Authors:  A Trinchieri
Journal:  Urol Res       Date:  2005-08-03

9.  Predictors of Bone Mineral Density in Kidney Stone Formers.

Authors:  Nasser A Dhayat; Lisa Schneider; Albrecht W Popp; David Lüthi; Cedric Mattmann; Bruno Vogt; Daniel G Fuster
Journal:  Kidney Int Rep       Date:  2021-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.